Qingdao Baheal Medical INC. (SHE:301015)
China flag China · Delayed Price · Currency is CNY
23.71
-1.11 (-4.47%)
Nov 17, 2026, 3:04 PM CST

SHE:301015 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
237.85474.69691.59712.06502.09421.64
Depreciation & Amortization
102.21102.2186.0286.1454.8641.18
Other Amortization
27.7827.786.25.276.6712.01
Loss (Gain) From Sale of Assets
-0.52-0.52-0.936.57-0.57-0.1
Asset Writedown & Restructuring Costs
0.60.60.460.350.040.01
Loss (Gain) From Sale of Investments
-96.51-96.51-56.85-48.58.87-9.77
Provision & Write-off of Bad Debts
7.927.9211.2632.8713.08-1.53
Other Operating Activities
59.57247.7163.65128.9236.8156.33
Change in Accounts Receivable
150.19150.19-85.14-104.15-386.9-373.68
Change in Inventory
-11.69-11.69-70.23-57.96-70.37-10.89
Change in Accounts Payable
61.8161.8164.549.02148.4539.62
Change in Other Net Operating Assets
-----0.2
Operating Cash Flow
509.48934.45813.85799.5305.75181.3
Operating Cash Flow Growth
-41.63%14.82%1.80%161.48%68.65%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Capital Expenditures
-219.14-288.93-303.99-185.49-105.32-27.49
Sale of Property, Plant & Equipment
0.380.40.796.090.910.13
Cash Acquisitions
---3.39--5.76-
Divestitures
--4.4316.357.786.11
Investment in Securities
-234.74-307.98-437.83-137.39-18.24-4.48
Other Investing Activities
5.247.77.684.733.32.9
Investing Cash Flow
-448.26-588.81-732.32-295.71-117.33-22.82

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Short-Term Debt Issued
---68.431,5711,188
Long-Term Debt Issued
-2,4162,1981,434--
Total Debt Issued
2,8862,4162,1981,5031,5711,188
Short-Term Debt Repaid
---304.96-21.1-1,530-1,374
Long-Term Debt Repaid
--1,295-938.63-1,460-33.82-26.09
Lease Payments
-34.27-34.27-20.47-32.51-33.82-26.09
Total Debt Repaid
-2,139-1,295-1,244-1,481-1,564-1,400
Net Debt Issued (Repaid)
747.081,121954.3221.627.14-212.25
Issuance of Common Stock
-----401.86
Common Dividends Paid
-381.46-467.57-449.86-440.11-402.22-55.72
Other Financing Activities
-353.32-288.25-499.7985.29-148.5-95.85
Financing Cash Flow
12.29365.484.67-333.2-543.5838.04

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Foreign Exchange Rate Adjustments
-15.74-9.732.210.725.87-1.18
Net Cash Flow
57.76701.488.4171.31-349.29195.33

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
290.34645.52509.86614.01200.43153.81
Free Cash Flow Growth
-48.91%26.61%-16.96%206.34%30.31%-
Free Cash Flow Margin
4.09%8.60%6.30%7.44%2.67%2.18%
Free Cash Flow Per Share
0.551.210.941.150.380.31
Levered Free Cash Flow
-16.81383.26791.34340.46171.7745.79
Unlevered Free Cash Flow
54.43448.04841.39385.29208.0683.96
Free Cash Flow After Leases
256.07611.25489.39581.5166.61127.72

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash Income Tax Paid
608.85641.35632.97600.08459.8384.21
Change in Working Capital
170.59170.59-87.55-124.17-316.12-338.47